ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1929

Timing Of Total Knee Arthroplasty: A Decision Analysis

Darena Tulanont1, Haily Vora1, Roopa Akkineni2 and Daniel A. Albert3,4, 1The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH, 2Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, 3Medicine/Rheumatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, 4Rheumatology, The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Total Knee Arthroplasty (TKA) and decision analysis

  • Tweet
  • Email
  • Print
Session Information

Title: Health Services Research, Quality Measures and Quality of Care - Innovations in Health Care Delivery

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Total Knee Arthroplasty (TKA) reduces pain and restores mobility.  However, replacement joints have limited durability and patients have to weight the benefits of having a knee replacement versus its lifespan, especially since revision arthroplasty has a higher complication rate and poorer outcomes.  The objective of this study is to determine the trade-off between undergoing TKA versus delaying TKA and thereby reducing the chance of revision.

Methods:

A Markov state-transition model was constructed to assess wait-times in patients undergoing TKA.  The model estimated the quality-adjusted-life-years (QALYs) for patients undergoing TKA at age 50 versus waiting until moderate or severe symptoms occur.  The model simulated a hypothetical cohort of patients 50-years and older.  The Western Ontario and McMaster Universities Arthritis Index (WOMAC) was used to classify mild, moderate and severe symptom levels.  Probabilities and quality adjustment measures were extracted from published literature.  Sensitivity analyses were performed on utilities for pain and wait time to undergo TKA. The model was simulated over the lifetime of an individual.

Results:

Compared to waiting until age 65, performing TKA at age 50 regardless of symptoms is the preferred strategy [22.73 QALYs versus 23.29 QALYs].  However, sensitivity analysis demonstrates that waiting is preferred for mild pain when utility is greater than 0.85; and moderate pain when utility is greater than 0.72.  In patients with severe pain TKA is always favored over waiting.  For a 50-year old patient with mild pain the natural history of osteoarthritis suggests progression to moderate or severe pain. Thus, our model indicates that patients presenting with mild pain will wait an average of 11.7 years (age 61.7 years; 23.40 QALYs) for TKA in order to maximize expected utility.

Conclusion:

TKA is the preferred strategy in individuals with severe knee pain.  For patients having mild pain, it is preferable to wait until moderate or severe pain develops.


Disclosure:

D. Tulanont,
None;

H. Vora,
None;

R. Akkineni,
None;

D. A. Albert,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/timing-of-total-knee-arthroplasty-a-decision-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology